908 Devices Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

908 Devices şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

0.4%

Geri Alım Getirisi

Toplam Hissedar Getirisi	0.4%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts

Nov 15

908 Devices: Key Investor Now Selling

Sep 08

Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

Aug 16

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: MASS şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: MASS şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

908 Devices Piyasaya Karşı Temettü Getirisi

MASS temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (MASS)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.2%
Sektör Ortalaması (Electronic)	2.3%
Analist tahmini (MASS) (3 yıla kadar)	n/a

Önemli Temettü: MASS şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, MASS şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: MASS şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: MASS herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

908 Devices Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts

908 Devices Inc. Reports Unaudited Consolidated Goodwill Impairment for the Third Quarter Ended September 30, 2024

908 Devices Inc. Reports Unaudited Consolidated Goodwill Impairment for the Third Quarter Ended September 30, 2024

908 Devices Inc. to Report Q3, 2024 Results on Nov 12, 2024

908 Devices: Key Investor Now Selling

Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

908 Devices Inc. Maintains Revenue Guidance for the Full Year 2024

908 Devices Inc. to Report Q2, 2024 Results on Aug 06, 2024

908 Devices Appoints Michele M. Leonhart to Board of Directors

908 Devices Enhances Xplorir Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

Co-Founder recently bought US$56k worth of stock

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc., Annual General Meeting, Jun 13, 2024

908 Devices Inc. (NasdaqGM:MASS) acquired CAM2 Technologies, LLC for $76.6 million.

908 Devices Inc. to Report Q1, 2024 Results on Apr 30, 2024

Co-Founder exercised options to buy US$263k worth of stock.

We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS exceeds analyst expectations

908 Devices Inc. Provides Earnings Guidance for the Full Year 2024

908 Devices Inc. to Report Q4, 2023 Results on Mar 05, 2024

CFO & Treasurer exercised options and sold US$109k worth of stock

CFO & Treasurer notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects

908 Devices Inc. Announces MX908 Integration Capabilities

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc. Provides Earnings Guidance for the Full Year 2023

New major risk - Revenue and earnings growth

908 Devices Inc. to Report Q3, 2023 Results on Nov 07, 2023

908 Devices Launches Maverick for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

New minor risk - Shareholder dilution

908 Devices Inc. Updates Revenue Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc Announces the Launch of MX908 Beacon

908 Devices Inc. to Report Q2, 2023 Results on Aug 08, 2023

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

908 Devices Inc. Provides Revenue Guidance for Full Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

908 Devices Inc. Launches Data Analysis Visualization Tool for REBEL at-Line Cell Culture Media Analyzer

Co-Founder notifies of intention to sell stock

Consensus EPS estimates fall by 22%

Full year 2022 earnings: EPS misses analyst expectations

908 Devices Inc. to Report Q4, 2022 Results on Mar 07, 2023

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

908 Devices Inc. Announces the Launch of Maven

Co-Founder notifies of intention to sell stock

Consensus revenue estimates fall by 12%

Co-Founder notifies of intention to sell stock

Third quarter 2022 earnings: EPS exceeds analyst expectations

908 Devices Inc. Updates Its Revenue Guidance for Full Year 2022

908 Devices Inc. Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

908 Devices Inc. to Report Q3, 2022 Results on Nov 14, 2022

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc. (NasdaqGM:MASS) acquired TRACE Analytics GmbH for $17.3 million,

908 Devices Q2 2022 Earnings Preview

VP, Secretary & General Counsel exercised options and sold US$161k worth of stock

908 Devices Inc. to Report Q2, 2022 Results on Aug 09, 2022

CFO & Treasurer exercised options and sold US$168k worth of stock

908 Devices Inc. Provides Earnings Guidance for the Full Year 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc. Advances MX908 Handheld Device Capabilities

Price target decreased to US$33.00

908 Devices Inc., Annual General Meeting, Jun 16, 2022

Vice President of Corporate Development exercised options and sold US$270k worth of stock

908 Devices Inc. to Report Q1, 2022 Results on May 10, 2022

Nicolas Barthelemy Announces Decision Not to Stand for Re-Election as Member of the Board of 908 Devices Inc

Co-Founder notifies of intention to sell stock

908 Devices Inc. Provides Revenue Guidance for the Year 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

908 Devices Inc. Appoints Tony J. Hunt to Its Board of Directors